Resolute Mining heads into the back half of September with an unusual split: the stock has handed back 7% on the week to AUD 1.37 while short sellers quietly doubled their positions — yet the borrow market shows no sign of pressure at all.
The short interest story is the week's most striking data point, even if the absolute level remains modest. Short positions climbed 36% over the past five trading days to around 16.4 million shares, equivalent to 0.77% of free float. That is a material rate-of-change for a position that was running near 26–27 million shares as recently as mid-August before collapsing through early September. The rebuild has been swift and deliberate — from roughly 11.6 million shares on September 3 to 16.4 million by September 10 — but still sits well below the summer peak. At less than 1% of float, this is not a crowded short. The borrow market confirms it: availability is effectively unlimited, well above 1,000% of outstanding short interest, meaning there is no friction for anyone who wants to initiate or extend a short position. Cost to borrow is negligible at 0.76% annualised, barely changed on the week. The ORTEX short score has edged up to 29.4 — its highest reading of the past two weeks — but remains in undemanding territory, consistent with a stock where the short-side activity is more tactical than structural.
The week's price action deserves some context, however. RSG fell 3.5% on Friday and 7.1% on the week, but that comes after a 20% gain over the prior month. The pullback looks more like profit-taking into broader ASX gold sector weakness than a standalone event. Peer names tell the same story: PRU dropped 5.3% on the week, RMS fell 5.6%, WGX shed 13%, and BGL lost 8.5%. WAF was the notable exception, holding nearly flat at -0.3%. RSG's 7% decline sits in the middle of the peer range — underperforming WAF, roughly in line with PRU and RMS, and well above WGX on the downside.
On valuation, Resolute trades at a trailing P/E of around 8.1x and EV/EBITDA near 3.1x — both of which have drifted modestly lower over the past seven days but remain materially higher than a month ago, reflecting that 20% run-up in August. The price-to-book multiple of 2.1x has gained 0.46 points over 30 days. An ORTEX analyst consensus target of AUD 1.86 implies roughly 36% upside from current levels, though that data was last refreshed in early August and no recent analyst changes are on record — so treat the target as directional rather than precise. The most recent stock score note from August flagged Growth and Quality as the leading pillars, with EPS expansion of around 170% forecast on a forward 12-month basis. That forward momentum has deteriorated somewhat in near-term EPS revisions, with 30-day momentum now negative, but the longer-run growth case remains intact.
On the ownership side, Helikon Investments holds a dominant 19.1% stake — adding 64 million shares in the period to August 10 — making it by far the largest holder and the clearest expression of conviction in this name. State Street (6.7%) and Dimensional (6.4%) round out the institutional register with smaller, steadier positions. Goldman Sachs added 63 million shares as of June, bringing its stake to just over 4%, which is worth monitoring given that type of accumulation from a trading-book counterparty can shift quickly. Insider activity has been limited: a director bought a small parcel of 15,000 shares in June, and a second director picked up around 5,000 shares last November at AUD 0.93 — a useful signal in context given the stock has since risen meaningfully, but neither trade carries enough size to read as a strong directional bet.
The next scheduled earnings event falls around October 30. The most recent results in August produced a one-day gain of 6.7% followed by a further 13.4% over five days, and a separate event on August 19 delivered a 10% immediate move and 22.6% over the week — a pattern of sharp post-result moves that will set the tempo for how the market approaches that October print. With the borrow pool wide open and short interest rebuilding modestly off low levels, the key question heading into that date is whether the near-term EPS momentum deterioration narrows further or whether the longer-run growth forecast holds the Street's confidence.
See the live data behind this article on ORTEX.
Open RSG on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
